(Q44087714)

29 November 2017

title

PAI-1 in human hypertension: relation to hypertensive groups (English)

1 reference

29 November 2017

4

Xavier Jeunemaitre

1 reference

29 November 2017

3

Paul N Hopkins

1 reference

29 November 2017

5

Steven C Hunt

1 reference

29 November 2017

Nadarajah Srikumar

1

1 reference

29 November 2017

Nancy J Brown

series ordinal

2

1 reference

29 November 2017

Douglas E Vaughan

series ordinal

6

1 reference

29 November 2017

Gordon H Williams

series ordinal

7

1 reference

29 November 2017

publication date

1 August 2002

1 reference

Journal of Clinical Hypertension

29 November 2017

published in

1 reference

29 November 2017

volume

15

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

683-690

1 reference

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Fibrinolytic function in diuretic-induced volume depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Relation of age, diastolic pressure and known duration of hypertension to presence of low renin essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902952-7

7 January 2021

10.1016/S0895-7061(02)02952-7

Identifiers

DOI

1 reference

29 November 2017

1 reference